Cancer tumors hijack genetic program of developing nerves, study shows

Cancer tumors “hijack” the genetic program used by developing nerves. This is shown in a study by researchers at Umeå University, Sweden.

New Mexico Takes Bold Steps Towards Psilocybin Therapy Research | Psychedelic Invest

In a remarkable show of bipartisan unity, a New Mexico Senate committee has recently cast a unanimous vote in favor of a resolution aimed at

February 14, 2024

Tenecteplase No Longer Off-Label as Stroke Lytic

The FDA approved tenecteplase (TNKase) for adult stroke patients, Genentech announced on Monday. A clot-dissolving tissue plasminogen activator (tPA), tenecteplase is now indicated for acute

March 4, 2025

New Guideline Revises Cautions Around Dental Work in Joint Replacement Patients

In an update 12 years in the making, two orthopedic surgeons’ organizations have issued new guidance on preventing periprosthetic joint infections (PJIs) when patients undergo

December 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.